References
- Jackson CE, Rosenfeld J. Motor neuron disease. Physical Medicine & Rehabilitation Clinics of North America 2001; 12(2): 335–352.
- Strong M. Amyotrophic Lateral Sclerosis. ALS and Other Motor Neuron Diseases 2003; 4: 1–8.
- Rosenfeld J. Multi-drug therapy for the treatment of ALS. Introduction. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2000; 1(Suppl 4): 1.
- Iwasaki Y, Ikeda K. Cotreatment of amyotrophic lateral sclerosis patients. Rinsho Shinkeigaku - Clinical Neurology 1999; 39(12): 1253–1255.
- Ludolph AC, Meyer T, Riepe MW. Antiglutamate therapy of ALS: which is the next step? Journal of Neural Transmission Supplementum 1999; 55: 79–95.
- Kriz J, Gowing G, Julien JP. Efficient three-drug cocktail for disease induced by mutant superoxide dismutase.[comment]. Annals of Neurology 2003; 53(4): 429–436.
- Kawamata T, Akiyama H, Yamada T, McGeer PL. Immuno- logical reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. American Journal of Pathology 1992; 140(3): 691–707.
- Cleveland DW, Rothstein JD. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS.[comment]. Nature Reviews Neuroscience 2001; 2(11): 806–819.
- Julien JP. Amyotrophic lateral sclerosis. unfolding the toxicity of the misfolded. Cell 2001; 104(4): 581–591.